世界の抗片頭痛薬市場:成長動向・競争分析2020-2026

【英語タイトル】Global Anti-Migraine Drugs Industry Research Report, Growth Trends and Competitive Analysis 2020-2026

QYResearchが出版した調査資料(QYR20AP00116)・商品コード:QYR20AP00116
・発行会社(調査会社):QYResearch
・発行日:2020年3月16日(※2024年版があります。お問い合わせください)
・ページ数:118
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥725,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD7,350 ⇒換算¥1,087,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD9,800 ⇒換算¥1,450,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
当リサーチレポートでは、抗片頭痛薬の世界市場規模が2019年xx百万ドルから2026年xx百万ドルまで年平均xx%成長すると予測しています。当レポートは、抗片頭痛薬のグローバル市場動向、メーカー別競争状況、種類別市場規模(トリプタン、麦角、その他)、用途別市場規模(女性、男性)、北米市場、アジア市場、中南米市場、中東・アフリカ市場分析、関連企業情報、サプライチェーン、販売チャネル分析、地域別市場規模予測データなどを掲載しています。

・レポート概要
・グローバル市場動向
・メーカー別競争状況
・抗片頭痛薬の種類別市場2015-2026:トリプタン、麦角、その他
・抗片頭痛薬の用途別市場2015-2026:女性、男性
・抗片頭痛薬の北米市場分析
・抗片頭痛薬のアジア市場分析
・抗片頭痛薬の中南米市場分析
・抗片頭痛薬の中東・アフリカ市場分析
・関連企業情報:Eli Lilly、Abbott Laboratories、Eisai、Allergan、Endo、GlaxoSmithKline、Impax Laboratories、Pfizer、AstraZeneca、Bayer、Johnson & Johnson、Merck、Teva、Amgen
・サプライチェーン及び販売チャネル分析
・地域別市場規模予測2021-2026:北米、ヨーロッパ、アジア、中南米、中東・アフリカ
・結論
【レポートの概要】

In 2019, the global Anti-Migraine Drugs market size was US$ xx million and is forecast to US$ xx million in 2026, growing at a CAGR of xx% from 2020. In this study, 2019 has been considered as the base year and 2020 to 2026 as the forecast period to estimate the market size for Anti-Migraine Drugs.The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Anti-Migraine Drugs market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Anti-Migraine Drugs market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Anti-Migraine Drugs market. Readers of the report can become informed about current and future trends of the global Anti-Migraine Drugs market and how they will impact market growth during the forecast period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise and country-wise Anti-Migraine Drugs markets such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E etc.
For the period 2015-2026, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Anti-Migraine Drugs market. For the period 2015-2020, it provides sales (consumption) analysis and forecast of different regional markets by Application as well as by Type in terms of volume.
Market Segmentation by Type and by Application
The report includes a detailed analysis of leading and by Type and by Application segments of the global Anti-Migraine Drugs market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue, sales analysis and forecast of the global Anti-Migraine Drugs market by Type and by Application segment for the period 2015-2026.

Market Segment by Type, the Anti-Migraine Drugs market is segmented into
Triptans
Ergots
Others

Market Segment by Application, the Anti-Migraine Drugs market is segmented into
Women
Men

This report includes the following manufacturers; we can also add the other companies as you want.
Eli Lilly
Abbott Laboratories
Eisai
Allergan
Endo
GlaxoSmithKline
Impax Laboratories
Pfizer
AstraZeneca
Bayer
Johnson & Johnson
Merck
Teva
Amgen

The study objectives are:
To analyze and research the global Anti-Migraine Drugs status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Anti-Migraine Drugs manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Anti-Migraine Drugs are as follows:
History Year: 2015-2020
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Top Anti-Migraine Drugs Manufacturers Covered: Ranking by Revenue
1.3 Market Segment by Type
1.3.1 Global Anti-Migraine Drugs Market Size by Type: 2015 VS 2020 VS 2026 (US$ Million)
1.3.2 Triptans
1.3.3 Ergots
1.3.4 Others
1.4 Market Segment by Application
1.4.1 Global Anti-Migraine Drugs Consumption by Application: 2015 VS 2020 VS 2026
1.4.2 Women
1.4.3 Men
1.5 Study Objectives
1.6 Years Considered
2 Global Market Perspective
2.1 Global Anti-Migraine Drugs Revenue (2015-2026)
2.1.1 Global Anti-Migraine Drugs Revenue (2015-2026)
2.1.2 Global Anti-Migraine Drugs Sales (2015-2026)
2.2 Anti-Migraine Drugs Market Size across Key Geographies Worldwide: 2015 VS 2020 VS 2026
2.2.1 Global Anti-Migraine Drugs Sales by Regions (2015-2020)
2.2.2 Global Anti-Migraine Drugs Revenue by Regions (2015-2020)
2.3 Global Top Anti-Migraine Drugs Regions (Countries) Ranking by Market Size
2.4 Anti-Migraine Drugs Industry Trends
2.4.1 Anti-Migraine Drugs Market Top Trends
2.4.2 Market Drivers
2.4.3 Anti-Migraine Drugs Market Challenges
2.4.4 Porter’s Five Forces Analysis
2.4.5 Primary Interviews with Key Anti-Migraine Drugs Players: Views for Future

3 Competitive Landscape by Manufacturers
3.1 Global Top Anti-Migraine Drugs Manufacturers by Sales (2015-2020)
3.1.1 Global Anti-Migraine Drugs Sales by Manufacturers (2015-2020)
3.1.2 Global Anti-Migraine Drugs Sales Market Share by Manufacturers (2015-2020)
3.1.3 Global 5 and 10 Largest Manufacturers by Anti-Migraine Drugs Sales in 2019
3.2 Global Top Manufacturers Anti-Migraine Drugs by Revenue
3.2.1 Global Anti-Migraine Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Global Anti-Migraine Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Anti-Migraine Drugs Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Migraine Drugs as of 2019)
3.4 Global Anti-Migraine Drugs Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Anti-Migraine Drugs Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Anti-Migraine Drugs Market
3.7 Key Manufacturers Anti-Migraine Drugs Product Offered
3.8 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Anti-Migraine Drugs Historic Market Review by Type (2015-2020)
4.1.2 Global Anti-Migraine Drugs Sales Market Share by Type (2015-2020)
4.1.3 Global Anti-Migraine Drugs Revenue Market Share by Type (2015-2020)
4.1.4 Anti-Migraine Drugs Price by Type (2015-2020)
4.1 Global Anti-Migraine Drugs Market Estimates and Forecasts by Type (2021-2026)
4.2.2 Global Anti-Migraine Drugs Sales Forecast by Type (2021-2026)
4.2.3 Global Anti-Migraine Drugs Revenue Forecast by Type (2021-2026)
4.2.4 Anti-Migraine Drugs Price Forecast by Type (2021-2026)

5 Global Anti-Migraine Drugs Market Size by Application
5.1 Global Anti-Migraine Drugs Historic Market Review by Application (2015-2020)
5.1.2 Global Anti-Migraine Drugs Sales Market Share by Application (2015-2020)
5.1.3 Global Anti-Migraine Drugs Revenue Market Share by Application (2015-2020)
5.1.4 Anti-Migraine Drugs Price by Application (2015-2020)
5.2 Global Anti-Migraine Drugs Market Estimates and Forecasts by Application (2021-2026)
5.2.2 Global Anti-Migraine Drugs Sales Forecast by Application (2021-2026)
5.2.3 Global Anti-Migraine Drugs Revenue Forecast by Application (2021-2026)
5.2.4 Anti-Migraine Drugs Price Forecast by Application (2021-2026)

6 North America
6.1 North America Anti-Migraine Drugs Breakdown Data by Company
6.2 North America Anti-Migraine Drugs Breakdown Data by Type
6.3 North America Anti-Migraine Drugs Breakdown Data by Application
6.4 North America Anti-Migraine Drugs Breakdown Data by Countries
6.4.1 North America Anti-Migraine Drugs Sales by Countries
6.4.2 North America Anti-Migraine Drugs Revenue by Countries
6.4.3 U.S.
6.4.4 Canada

7 Europe
7.1 Europe Anti-Migraine Drugs Breakdown Data by Company
7.2 Europe Anti-Migraine Drugs Breakdown Data by Type
7.3 Europe Anti-Migraine Drugs Breakdown Data by Application
7.4 Europe Anti-Migraine Drugs Breakdown Data by Countries
7.4.1 Europe Anti-Migraine Drugs Sales by Countries
7.4.2 Europe Anti-Migraine Drugs Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Anti-Migraine Drugs Breakdown Data by Company
8.2 Asia Pacific Anti-Migraine Drugs Breakdown Data by Type
8.3 Asia Pacific Anti-Migraine Drugs Breakdown Data by Application
8.4 Asia Pacific Anti-Migraine Drugs Breakdown Data by Regions
8.4.1 Asia Pacific Anti-Migraine Drugs Sales by Regions
8.4.2 Asia Pacific Anti-Migraine Drugs Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam

9 Latin America
9.1 Latin America Anti-Migraine Drugs Breakdown Data by Company
9.2 Latin America Anti-Migraine Drugs Breakdown Data by Type
9.3 Latin America Anti-Migraine Drugs Breakdown Data by Application
9.4 Latin America Anti-Migraine Drugs Breakdown Data by Countries
9.4.1 Latin America Anti-Migraine Drugs Sales by Countries
9.4.2 Latin America Anti-Migraine Drugs Revenue by Countries
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Anti-Migraine Drugs Breakdown Data by Type
10.2 Middle East and Africa Anti-Migraine Drugs Breakdown Data by Application
10.3 Middle East and Africa Anti-Migraine Drugs Breakdown Data by Countries
10.3.1 Middle East and Africa Anti-Migraine Drugs Sales by Countries
10.3.2 Middle East and Africa Anti-Migraine Drugs Revenue by Countries
10.3.3 Turkey
10.3.4 Saudi Arabia
10.3.5 U.A.E

11 Company Profiles
11.1 Eli Lilly
11.1.1 Eli Lilly Corporation Information
11.1.2 Eli Lilly Business Overview and Total Revenue (2019 VS 2018)
11.1.3 Eli Lilly Anti-Migraine Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.1.4 Eli Lilly Anti-Migraine Drugs Products and Services
11.1.5 Eli Lilly SWOT Analysis
11.1.6 Eli Lilly Recent Developments
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Corporation Information
11.2.2 Abbott Laboratories Business Overview and Total Revenue (2019 VS 2018)
11.2.3 Abbott Laboratories Anti-Migraine Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.2.4 Abbott Laboratories Anti-Migraine Drugs Products and Services
11.2.5 Abbott Laboratories SWOT Analysis
11.2.6 Abbott Laboratories Recent Developments
11.3 Eisai
11.3.1 Eisai Corporation Information
11.3.2 Eisai Business Overview and Total Revenue (2019 VS 2018)
11.3.3 Eisai Anti-Migraine Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.3.4 Eisai Anti-Migraine Drugs Products and Services
11.3.5 Eisai SWOT Analysis
11.3.6 Eisai Recent Developments
11.4 Allergan
11.4.1 Allergan Corporation Information
11.4.2 Allergan Business Overview and Total Revenue (2019 VS 2018)
11.4.3 Allergan Anti-Migraine Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.4.4 Allergan Anti-Migraine Drugs Products and Services
11.4.5 Allergan SWOT Analysis
11.4.6 Allergan Recent Developments
11.5 Endo
11.5.1 Endo Corporation Information
11.5.2 Endo Business Overview and Total Revenue (2019 VS 2018)
11.5.3 Endo Anti-Migraine Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.5.4 Endo Anti-Migraine Drugs Products and Services
11.5.5 Endo SWOT Analysis
11.5.6 Endo Recent Developments
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Corporation Information
11.6.2 GlaxoSmithKline Business Overview and Total Revenue (2019 VS 2018)
11.6.3 GlaxoSmithKline Anti-Migraine Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.6.4 GlaxoSmithKline Anti-Migraine Drugs Products and Services
11.6.5 GlaxoSmithKline SWOT Analysis
11.6.6 GlaxoSmithKline Recent Developments
11.7 Impax Laboratories
11.7.1 Impax Laboratories Corporation Information
11.7.2 Impax Laboratories Business Overview and Total Revenue (2019 VS 2018)
11.7.3 Impax Laboratories Anti-Migraine Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.7.4 Impax Laboratories Anti-Migraine Drugs Products and Services
11.7.5 Impax Laboratories SWOT Analysis
11.7.6 Impax Laboratories Recent Developments
11.8 Pfizer
11.8.1 Pfizer Corporation Information
11.8.2 Pfizer Business Overview and Total Revenue (2019 VS 2018)
11.8.3 Pfizer Anti-Migraine Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.8.4 Pfizer Anti-Migraine Drugs Products and Services
11.8.5 Pfizer SWOT Analysis
11.8.6 Pfizer Recent Developments
11.9 AstraZeneca
11.9.1 AstraZeneca Corporation Information
11.9.2 AstraZeneca Business Overview and Total Revenue (2019 VS 2018)
11.9.3 AstraZeneca Anti-Migraine Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.9.4 AstraZeneca Anti-Migraine Drugs Products and Services
11.9.5 AstraZeneca SWOT Analysis
11.9.6 AstraZeneca Recent Developments
11.10 Bayer
11.10.1 Bayer Corporation Information
11.10.2 Bayer Business Overview and Total Revenue (2019 VS 2018)
11.10.3 Bayer Anti-Migraine Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.10.4 Bayer Anti-Migraine Drugs Products and Services
11.10.5 Bayer SWOT Analysis
11.10.6 Bayer Recent Developments
11.11 Johnson & Johnson
11.11.1 Johnson & Johnson Corporation Information
11.11.2 Johnson & Johnson Business Overview and Total Revenue (2019 VS 2018)
11.11.3 Johnson & Johnson Anti-Migraine Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.11.4 Johnson & Johnson Anti-Migraine Drugs Products and Services
11.11.5 Johnson & Johnson SWOT Analysis
11.11.6 Johnson & Johnson Recent Developments
11.12 Merck
11.12.1 Merck Corporation Information
11.12.2 Merck Business Overview and Total Revenue (2019 VS 2018)
11.12.3 Merck Anti-Migraine Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.12.4 Merck Anti-Migraine Drugs Products and Services
11.12.5 Merck SWOT Analysis
11.12.6 Merck Recent Developments
11.13 Teva
11.13.1 Teva Corporation Information
11.13.2 Teva Business Overview and Total Revenue (2019 VS 2018)
11.13.3 Teva Anti-Migraine Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.13.4 Teva Anti-Migraine Drugs Products and Services
11.13.5 Teva SWOT Analysis
11.13.6 Teva Recent Developments
11.14 Amgen
11.14.1 Amgen Corporation Information
11.14.2 Amgen Business Overview and Total Revenue (2019 VS 2018)
11.14.3 Amgen Anti-Migraine Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.14.4 Amgen Anti-Migraine Drugs Products and Services
11.14.5 Amgen SWOT Analysis
11.14.6 Amgen Recent Developments

12 Supply Chain and Sales Channels Analysis
12.1 Supply Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Anti-Migraine Drugs Sales Channels
12.2.2 Anti-Migraine Drugs Distributors
12.3 Anti-Migraine Drugs Customers

13 Estimates and Projections by Regions (2021-2026)
13.1 Global Anti-Migraine Drugs Sales Forecast (2021-2026)
13.1.1 Global Anti-Migraine Drugs Sales Forecast by Regions (2021-2026)
13.1.2 Global Anti-Migraine Drugs Revenue Forecast by Regions (2021-2026)
13.2 North America Market Size Forecast (2021-2026)
13.2.1 North America Anti-Migraine Drugs Sales Forecast (2021-2026)
13.2.2 North America Anti-Migraine Drugs Revenue Forecast (2021-2026)
13.2.3 North America Anti-Migraine Drugs Size Forecast by County (2021-2026)
13.3 Europe Market Size Forecast (2021-2026)
13.3.1 Europe Anti-Migraine Drugs Sales Forecast (2021-2026)
13.3.2 Europe Anti-Migraine Drugs Revenue Forecast (2021-2026)
13.3.3 Europe Anti-Migraine Drugs Size Forecast by County (2021-2026)
13.4 Asia Pacific Market Size Forecast (2021-2026)
13.4.1 Asia Pacific Anti-Migraine Drugs Sales Forecast (2021-2026)
13.4.2 Asia Pacific Anti-Migraine Drugs Revenue Forecast (2021-2026)
13.4.3 Asia Pacific Anti-Migraine Drugs Size Forecast by Region (2021-2026)
13.5 Latin America Market Size Forecast (2021-2026)
13.5.1 Latin America Anti-Migraine Drugs Sales Forecast (2021-2026)
13.5.2 Latin America Anti-Migraine Drugs Revenue Forecast (2021-2026)
13.5.3 Latin America Anti-Migraine Drugs Size Forecast by County (2021-2026)
13.6 Middle East and Africa Market Forecast
13.6.1 Middle East and Africa Anti-Migraine Drugs Sales Forecast (2021-2026)
13.6.2 Middle East and Africa Anti-Migraine Drugs Revenue Forecast (2021-2026)
13.6.3 Middle East and Africa Anti-Migraine Drugs Size Forecast by County (2021-2026)

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Anti-Migraine Drugs Key Market Segments
Table 2. Ranking of Global Top Anti-Migraine Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Anti-Migraine Drugs Market Size Growth Rate by Type 2021-2026 (K Units) & (Million US$)
Table 4. Major Manufacturers of Triptans
Table 5. Major Manufacturers of Ergots
Table 6. Major Manufacturers of Others
Table 7. Global Anti-Migraine Drugs Market Share by Application 2019-2025 (K Units)
Table 8. Global Anti-Migraine Drugs Market Size by Regions 2015-2020 (K Units) & (Million US$)
Table 9. Global Anti-Migraine Drugs Sales by Regions 2015-2020 (K Units)
Table 10. Global Anti-Migraine Drugs Sales Market Share by Regions 2015-2020
Table 11. Global Anti-Migraine Drugs Revenue by Regions 2015-2020 (Million US$)
Table 12. Global Anti-Migraine Drugs Revenue Market Share by Regions 2015-2020
Table 13. Top Anti-Migraine Drugs Regions (Countries) Ranking by Market Size (US$ Million) in 2019
Table 14. Market Top Trends
Table 15. Anti-Migraine Drugs Key Drivers: Impact Analysis (2021-2026)
Table 16. Anti-Migraine Drugs Key Challenges
Table 17. Main Points Interviewed from Key Anti-Migraine Drugs Players: Views for Future
Table 18. Global Anti-Migraine Drugs Sales by Manufacturers (2015-2020) (K Units)
Table 19. Global Anti-Migraine Drugs Sales Share by Manufacturers (2015-2020)
Table 20. Anti-Migraine Drugs Revenue by Manufacturers (2015-2020) (Million US$)
Table 21. Anti-Migraine Drugs Revenue Share by Manufacturers (2015-2020)
Table 22. Global Anti-Migraine Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Migraine Drugs as of 2019)
Table 24. Key Manufacturers Anti-Migraine Drugs Average Selling Price (ASP) (2015-2020) (USD/Pcs)
Table 25. Key Manufacturers Anti-Migraine Drugs Plants/Factories Distribution
Table 26. Key Manufacturers Anti-Migraine Drugs Area Served
Table 27. Date of Key Manufacturers Enter into Anti-Migraine Drugs Market
Table 28. Key Manufacturers Anti-Migraine Drugs Product Type
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Triptans Sales and Revenue (2015-2020) (K Units) & (Million US$)
Table 31. Global Ergots Sales and Revenue (2015-2020) (K Units) & (Million US$)
Table 32. Global Others Sales ana Revenue (2015-2020) (K Units) & (Million US$)
Table 33. Global Anti-Migraine Drugs Sales (K Units) by Type (2015-2020)
Table 34. Global Anti-Migraine Drugs Sales Share by Type (2015-2020)
Table 35. Global Anti-Migraine Drugs Revenue (US$ Million) Market Share by Type (2015-2020)
Table 36. Global Anti-Migraine Drugs Price (K Units) by Type (2015-2020)
Table 37. Global Anti-Migraine Drugs Sales (K Units) by Type (2021-2026)
Table 38. Global Anti-Migraine Drugs Sales Share by Type (2021-2026)
Table 39. Global Anti-Migraine Drugs Revenue (US$ Million) Market Share by Type (2021-2026)
Table 40. Global Anti-Migraine Drugs Revenue Share by Type (2021-2026)
Table 41. Global Anti-Migraine Drugs Price (K Units) by Type (2021-2026)
Table 42. Global Anti-Migraine Drugs Sales (K Units) by Application (2015-2020)
Table 43. Global Anti-Migraine Drugs Sales Share by Application (2015-2020)
Table 44. Global Anti-Migraine Drugs Revenue (US$ Million) Market Share by Application (2015-2020)
Table 45. Global Anti-Migraine Drugs Price by Application 2015-2020 (USD/Pcs)
Table 46. Global Anti-Migraine Drugs Sales by Application (2015-2020) (K Units)
Table 47. Global Anti-Migraine Drugs Sales Share by Application (2015-2020)
Table 48. Global Anti-Migraine Drugs Revenue (US$ Million) Market Share by Application (2021-2026)
Table 49. Global Anti-Migraine Drugs Revenue Share by Application (2021-2026)
Table 50. Global Anti-Migraine Drugs Price (K Units) by Application (2021-2026)
Table 51. North America Anti-Migraine Drugs Sales by Company (2015-2020) (K Units)
Table 52. North America Anti-Migraine Drugs Sales Market Share by Company (2015-2020)
Table 53. North America Anti-Migraine Drugs Sales by Type (2015-2020) (K Units)
Table 54. North America Anti-Migraine Drugs Sales Market Share by Type (2015-2020)
Table 55. North America Anti-Migraine Drugs Sales by Application (2015-2020) (K Units)
Table 56. North America Anti-Migraine Drugs Sales Market Share by Application (2015-2020)
Table 57. North America Anti-Migraine Drugs Sales by Countries (2015-2020) (K Units)
Table 58. North America Anti-Migraine Drugs Sales Market Share by Countries (2015-2020)
Table 59. North America Anti-Migraine Drugs Revenue by Countries (2015-2020) (Million US$)
Table 60. North America Anti-Migraine Drugs Revenue Market Share by Countries (2015-2020)
Table 61. Europe Anti-Migraine Drugs Sales by Company (2015-2020) (K Units)
Table 62. Europe Anti-Migraine Drugs Sales Market Share by Company (2015-2020)
Table 63. Europe Anti-Migraine Drugs Sales by Type (2015-2020) (K Units)
Table 64. Europe Anti-Migraine Drugs Sales Market Share by Type (2015-2020)
Table 65. Europe Anti-Migraine Drugs Sales by Application (2015-2020) (K Units)
Table 66. Europe Anti-Migraine Drugs Sales Market Share by Application (2015-2020)
Table 67. Europe Anti-Migraine Drugs Sales by Countries (2015-2020) (K Units)
Table 68. Europe Anti-Migraine Drugs Sales Market Share by Countries (2015-2020)
Table 69. Europe Anti-Migraine Drugs Revenue by Countries (2015-2020) (Million US$)
Table 70. Europe Anti-Migraine Drugs Revenue Market Share by Countries (2015-2020)
Table 71. Asia Pacific Anti-Migraine Drugs Sales by Regions (2015-2020) (K Units)
Table 72. Asia Pacific Anti-Migraine Drugs Sales Market Share by Regions (2015-2020)
Table 73. Asia Pacific Anti-Migraine Drugs Sales by Type (2015-2020) (K Units)
Table 74. Asia Pacific Anti-Migraine Drugs Sales Market Share by Type (2015-2020)
Table 75. Asia Pacific Anti-Migraine Drugs Sales by Application (2015-2020) (K Units)
Table 76. Asia Pacific Anti-Migraine Drugs Sales Market Share by Application (2015-2020)
Table 77. Asia Pacific Anti-Migraine Drugs Sales by Countries (2015-2020) (K Units)
Table 78. Asia Pacific Anti-Migraine Drugs Sales Market Share by Regions (2015-2020)
Table 79. Asia Pacific Anti-Migraine Drugs Revenue by Regions (2015-2020) (Million US$)
Table 80. Asia Pacific Anti-Migraine Drugs Revenue Market Share by Regions (2015-2020)
Table 81. Latin America Anti-Migraine Drugs Sales by Company (2015-2020) (K Units)
Table 82. Latin America Anti-Migraine Drugs Sales Market Share by Company (2015-2020)
Table 83. Latin America Anti-Migraine Drugs Sales by Type (2015-2020) (K Units)
Table 84. Latin America Anti-Migraine Drugs Sales Market Share by Type (2015-2020)
Table 85. Latin America Anti-Migraine Drugs Sales by Application (2015-2020) (K Units)
Table 86. Latin America Anti-Migraine Drugs Sales Market Share by Application (2015-2020)
Table 87. Latin America Anti-Migraine Drugs Sales by Countries (2015-2020) (K Units)
Table 88. Latin America Anti-Migraine Drugs Sales Market Share by Countries (2015-2020)
Table 89. Latin America Anti-Migraine Drugs Revenue by Countries (2015-2020) (Million US$)
Table 90. Latin America Anti-Migraine Drugs Revenue Market Share by Countries (2015-2020)
Table 91. Middle East and Africa Anti-Migraine Drugs Sales by Type (2015-2020) (K Units)
Table 92. Middle East and Africa Anti-Migraine Drugs Sales Market Share by Type (2015-2020)
Table 93. Middle East and Africa Anti-Migraine Drugs Sales by Application (2015-2020) (K Units)
Table 94. Middle East and Africa Anti-Migraine Drugs Sales Market Share by Application (2015-2020)
Table 95. Middle East and Africa Anti-Migraine Drugs Sales by Countries (2015-2020) (K Units)
Table 96. Middle East and Africa Anti-Migraine Drugs Sales Market Share by Countries (2015-2020)
Table 97. Middle East and Africa Anti-Migraine Drugs Revenue by Countries (2015-2020) (Million US$)
Table 98. Middle East and Africa Anti-Migraine Drugs Revenue Market Share by Countries (2015-2020)
Table 99. Eli Lilly Company Details
Table 100. Eli Lilly Description and Business Overview
Table 101. Eli Lilly Anti-Migraine Drugs Sales (K Units), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 102. Eli Lilly Anti-Migraine Drugs Sales Growth Rate (2015-2020)
Table 103. Eli Lilly Anti-Migraine Drugs Sales Market Share in Global Market
Table 104. Eli Lilly Recent Development
Table 105. Abbott Laboratories Company Details
Table 106. Abbott Laboratories Description and Business Overview
Table 107. Abbott Laboratories Anti-Migraine Drugs Sales (K Units), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 108. Abbott Laboratories Anti-Migraine Drugs Sales Growth Rate (2015-2020)
Table 109. Abbott Laboratories Anti-Migraine Drugs Sales Market Share in Global Market
Table 110. Abbott Laboratories Recent Development
Table 111. Eisai Company Details
Table 112. Eisai Description and Business Overview
Table 113. Eisai Anti-Migraine Drugs Sales (K Units), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 114. Eisai Anti-Migraine Drugs Sales Growth Rate (2015-2020)
Table 115. Eisai Anti-Migraine Drugs Sales Market Share in Global Market
Table 116. Eisai Recent Development
Table 117. Allergan Company Details
Table 118. Allergan Description and Business Overview
Table 119. Allergan Anti-Migraine Drugs Sales (K Units), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 120. Allergan Anti-Migraine Drugs Sales Growth Rate (2015-2020)
Table 121. Allergan Anti-Migraine Drugs Sales Market Share in Global Market
Table 122. Allergan Recent Development
Table 123. Endo Company Details
Table 124. Endo Description and Business Overview
Table 125. Endo Anti-Migraine Drugs Sales (K Units), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 126. Endo Anti-Migraine Drugs Sales Growth Rate (2015-2020)
Table 127. Endo Anti-Migraine Drugs Sales Market Share in Global Market
Table 128. Endo Recent Development
Table 129. GlaxoSmithKline Company Details
Table 130. GlaxoSmithKline Description and Business Overview
Table 131. GlaxoSmithKline Anti-Migraine Drugs Sales (K Units), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 132. GlaxoSmithKline Anti-Migraine Drugs Sales Growth Rate (2015-2020)
Table 133. GlaxoSmithKline Anti-Migraine Drugs Sales Market Share in Global Market
Table 134. GlaxoSmithKline Recent Development
Table 135. Impax Laboratories Company Details
Table 136. Impax Laboratories Description and Business Overview
Table 137. Impax Laboratories Anti-Migraine Drugs Sales (K Units), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 138. Impax Laboratories Anti-Migraine Drugs Sales Growth Rate (2015-2020)
Table 139. Impax Laboratories Anti-Migraine Drugs Sales Market Share in Global Market
Table 140. Impax Laboratories Recent Development
Table 141. Pfizer Company Details
Table 142. Pfizer Description and Business Overview
Table 143. Pfizer Anti-Migraine Drugs Sales (K Units), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 144. Pfizer Anti-Migraine Drugs Sales Growth Rate (2015-2020)
Table 145. Pfizer Anti-Migraine Drugs Sales Market Share in Global Market
Table 146. Pfizer Recent Development
Table 147. AstraZeneca Company Details
Table 148. AstraZeneca Description and Business Overview
Table 149. AstraZeneca Anti-Migraine Drugs Sales (K Units), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 150. AstraZeneca Anti-Migraine Drugs Sales Growth Rate (2015-2020)
Table 151. AstraZeneca Anti-Migraine Drugs Sales Market Share in Global Market
Table 152. AstraZeneca Recent Development
Table 153. Bayer Company Details
Table 154. Bayer Description and Business Overview
Table 155. Bayer Anti-Migraine Drugs Sales (K Units), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 156. Bayer Anti-Migraine Drugs Sales Growth Rate (2015-2020)
Table 157. Bayer Anti-Migraine Drugs Sales Market Share in Global Market
Table 158. Bayer Recent Development
Table 159. Johnson & Johnson Company Details
Table 160. Johnson & Johnson Description and Business Overview
Table 161. Johnson & Johnson Anti-Migraine Drugs Sales (K Units), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 162. Johnson & Johnson Anti-Migraine Drugs Sales Growth Rate (2015-2020)
Table 163. Johnson & Johnson Anti-Migraine Drugs Sales Market Share in Global Market
Table 164. Johnson & Johnson Recent Development
Table 165. Merck Company Details
Table 166. Merck Description and Business Overview
Table 167. Merck Anti-Migraine Drugs Sales (K Units), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 168. Merck Anti-Migraine Drugs Sales Growth Rate (2015-2020)
Table 169. Merck Anti-Migraine Drugs Sales Market Share in Global Market
Table 170. Merck Recent Development
Table 171. Teva Company Details
Table 172. Teva Description and Business Overview
Table 173. Teva Anti-Migraine Drugs Sales (K Units), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 174. Teva Anti-Migraine Drugs Sales Growth Rate (2015-2020)
Table 175. Teva Anti-Migraine Drugs Sales Market Share in Global Market
Table 176. Teva Recent Development
Table 177. Amgen Company Details
Table 178. Amgen Description and Business Overview
Table 179. Amgen Anti-Migraine Drugs Sales (K Units), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 180. Amgen Anti-Migraine Drugs Sales Growth Rate (2015-2020)
Table 181. Amgen Anti-Migraine Drugs Sales Market Share in Global Market
Table 182. Amgen Recent Development
Table 183. Anti-Migraine Drugs Distributors List
Table 184. Anti-Migraine Drugs Customers List
Table 185. Global Anti-Migraine Drugs Sales Forecast 2021-2026 (K Units) & (Million US$)
Table 186. Global Anti-Migraine Drugs Sales Forecast by Type 2021-2026 (K Units)
Table 187. Global Anti-Migraine Drugs Sales Forecast by Application 2021-2026 (K Units)
Table 188. Global Anti-Migraine Drugs Sales Forecast by Regions 2021-2026 (K Units)
Table 189. Global Anti-Migraine Drugs Revenue Forecast by Regions 2021-2026 (Million US$)
Table 190. North America Anti-Migraine Drugs Sales Forecast by Countries 2021-2026 (K Units)
Table 191. North America Anti-Migraine Drugs Revenue Forecast by Countries 2021-2026
Table 192. Europe Anti-Migraine Drugs Sales Forecast by Countries 2021-2026 (K Units)
Table 193. Europe Anti-Migraine Drugs Revenue Market Share Forecast by Countries 2021-2026
Table 194. Asia Pacific Anti-Migraine Drugs Sales Forecast by Regions 2021-2026 (K Units)
Table 195. Asia Pacific Anti-Migraine Drugs Revenue Forecast by Regions 2021-2026 (Million US$)
Table 196. Latin America Anti-Migraine Drugs Sales Forecast by Countries 2021-2026 (K Units)
Table 197. Latin America Anti-Migraine Drugs Revenue Forecast by Countries 2021-2026 (Million US$)
Table 198. Middle East and Africa Anti-Migraine Drugs Sales Forecast by Regions 2021-2026 (K Units)
Table 199. Middle East and Africa Anti-Migraine Drugs Revenue Forecast by Regions 2021-2026 (Million US$)
Table 200. Research Programs/Design for This Report
Table 201. Key Data Information from Secondary Sources
Table 202. Key Data Information from Primary Sources
List of Figures
Figure 1. Anti-Migraine Drugs Product Picture
Figure 2. Global Anti-Migraine Drugs Sales Market Shar by Type 2015-2026
Figure 3. Triptans Figures
Figure 4. Ergots Figures
Figure 5. Others Figures
Figure 6. Global Anti-Migraine Drugs Sales Market Share by Application in 2019 & 2026
Figure 7. Women Use Case
Figure 8. Men Use Case
Figure 9. Anti-Migraine Drugs Report Years Considered
Figure 10. Global Anti-Migraine Drugs Market Size 2015-2026 (Million US$)
Figure 11. Global Anti-Migraine Drugs Sales 2015-2020 (K Units)
Figure 12. Global Anti-Migraine Drugs Market Size Market Share by Regions 2015-2020
Figure 13. Global Anti-Migraine Drugs Sales Market Share by Regions in 2019
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Anti-Migraine Drugs Sales Share by Manufacturers in 2019
Figure 16. The 5 and 10 Largest Manufacturers in the World: Market Share by Anti-Migraine Drugs Sales in 2019
Figure 17. Anti-Migraine Drugs Value Share by Manufacturers in 2019
Figure 18. Anti-Migraine Drugs Revenue Share by Manufacturers In 2019
Figure 19. Anti-Migraine Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Anti-Migraine Drugs Revenue Share by Type (2015-2020)
Figure 21. Global Anti-Migraine Drugs Revenue Growth Rate by Type in 2015 & 2019
Figure 22. Global Anti-Migraine Drugs Market Share by Price Range (2015-2020)
Figure 23. Global Anti-Migraine Drugs Revenue Share by Application (2015-2020)
Figure 24. Global Anti-Migraine Drugs Revenue Growth Rate by Application in 2015 & 2019
Figure 25. North America Anti-Migraine Drugs Revenue Growth Rate 2015-2020 (Million US$)
Figure 26. U.S. Anti-Migraine Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 27. Canada Anti-Migraine Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 28. Europe Anti-Migraine Drugs Revenue Growth Rate 2015-2020 (Million US$)
Figure 29. Germany Anti-Migraine Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 30. France Anti-Migraine Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 31. U.K. Anti-Migraine Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 32. Italy Anti-Migraine Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 33. Russia Anti-Migraine Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 34. Asia Pacific Anti-Migraine Drugs Revenue Growth Rate 2015-2020 (Million US$)
Figure 35. China Anti-Migraine Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 36. Japan Anti-Migraine Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 37. South Korea Anti-Migraine Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 38. India Anti-Migraine Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 39. Australia Anti-Migraine Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 40. Taiwan Anti-Migraine Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 41. Indonesia Anti-Migraine Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 42. Thailand Anti-Migraine Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 43. Malaysia Anti-Migraine Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 44. Philippines Anti-Migraine Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 45. Vietnam Anti-Migraine Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 46. Latin America Anti-Migraine Drugs Revenue Growth Rate 2015-2020 (Million US$)
Figure 47. Mexico Anti-Migraine Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 48. Brazil Anti-Migraine Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 49. Argentina Anti-Migraine Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 50. Middle East and Africa Anti-Migraine Drugs Revenue Growth Rate 2015-2020 (Million US$)
Figure 51. Turkey Anti-Migraine Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 52. Saudi Arabia Anti-Migraine Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 53. U.A.E Anti-Migraine Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 54. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Abbott Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Eisai Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Allergan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Endo Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Impax Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 65. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 66. Teva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 67. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 68. Anti-Migraine Drugs Value Chain
Figure 69. Channels of Distribution
Figure 70. Distributors Profiles
Figure 71. North America Anti-Migraine Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 72. North America Anti-Migraine Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 73. Europe Anti-Migraine Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 74. Europe Anti-Migraine Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 75. Asia Pacific Anti-Migraine Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 76. Asia Pacific Anti-Migraine Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 77. Latin America Anti-Migraine Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 78. Latin America Anti-Migraine Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 79. Middle East and Africa Anti-Migraine Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 80. Middle East and Africa Anti-Migraine Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 81. Bottom-up and Top-down Approaches for This Report
Figure 82. Data Triangulation
Figure 83. Key Executives Interviewed


【掲載企業】

Eli Lilly、Abbott Laboratories、Eisai、Allergan、Endo、GlaxoSmithKline、Impax Laboratories、Pfizer、AstraZeneca、Bayer、Johnson & Johnson、Merck、Teva、Amgen

★調査レポート[世界の抗片頭痛薬市場:成長動向・競争分析2020-2026] (コード:QYR20AP00116)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の抗片頭痛薬市場:成長動向・競争分析2020-2026]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆